These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12819780)

  • 1. Imaging 26S proteasome activity and inhibition in living mice.
    Luker GD; Pica CM; Song J; Luker KE; Piwnica-Worms D
    Nat Med; 2003 Jul; 9(7):969-73. PubMed ID: 12819780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer.
    Shah SA; Potter MW; McDade TP; Ricciardi R; Perugini RA; Elliott PJ; Adams J; Callery MP
    J Cell Biochem; 2001 Apr 2-27; 82(1):110-22. PubMed ID: 11400168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter.
    Momose I; Tatsuda D; Ohba S; Masuda T; Ikeda D; Nomoto A
    Cancer Sci; 2012 Sep; 103(9):1730-6. PubMed ID: 22676179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.
    Yerlikaya A; DoKudur H
    Mol Biol (Mosk); 2010; 44(5):859-66. PubMed ID: 21090173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
    van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
    J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.
    Csizmadia V; Csizmadia E; Silverman L; Simpson C; Raczynski A; O'Brien L; Gallacher M; Cardoza K; Kadambi VJ; Fedyk ER; Alden CL
    Vet Pathol; 2010 Mar; 47(2):358-67. PubMed ID: 20124009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
    Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Marti RM; Matias-Guiu X; Dolcet X
    Anticancer Drugs; 2008 Feb; 19(2):115-24. PubMed ID: 18176107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
    Cusack JC; Liu R; Houston M; Abendroth K; Elliott PJ; Adams J; Baldwin AS
    Cancer Res; 2001 May; 61(9):3535-40. PubMed ID: 11325813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib.
    Uyama M; Sato MM; Kawanami M; Tamura M
    Genes Cells; 2012 Jul; 17(7):548-58. PubMed ID: 22702336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    Fineschi S; Reith W; Guerne PA; Dayer JM; Chizzolini C
    FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
    Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Fanourakis G; Gu X; Bailey C; Joseph M; Libermann TA; Treon SP; Munshi NC; Richardson PG; Hideshima T; Anderson KC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14374-9. PubMed ID: 12391322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring proteasome activity in cellulo and in living animals by bioluminescent imaging: technical considerations for design and use of genetically encoded reporters.
    Gross S; Piwnica-Worms D
    Methods Enzymol; 2005; 399():512-30. PubMed ID: 16338379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome.
    Bold RJ; Virudachalam S; McConkey DJ
    J Surg Res; 2001 Sep; 100(1):11-7. PubMed ID: 11516199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27 degradation by an ellipticinium series of compound via ubiquitin-proteasome pathway.
    Pamarthy D; Tan M; Wu M; Chen J; Yang D; Wang S; Zhang H; Sun Y
    Cancer Biol Ther; 2007 Mar; 6(3):360-6. PubMed ID: 17312389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-associated protein-43 is degraded via the ubiquitin-proteasome system.
    De Moliner KL; Wolfson ML; Perrone Bizzozero N; Adamo AM
    J Neurosci Res; 2005 Mar; 79(5):652-60. PubMed ID: 15668958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification and synthesis of ubiquitin-proteasome inhibitor].
    Li J; Zhang DY; Wu XM
    Yao Xue Xue Bao; 2009 Dec; 44(12):1313-9. PubMed ID: 21351462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.
    Blackburn C; Gigstad KM; Hales P; Garcia K; Jones M; Bruzzese FJ; Barrett C; Liu JX; Soucy TA; Sappal DS; Bump N; Olhava EJ; Fleming P; Dick LR; Tsu C; Sintchak MD; Blank JL
    Biochem J; 2010 Sep; 430(3):461-76. PubMed ID: 20632995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacodynamic imaging of proteasome inhibition.
    Kimbrel EA; Davis TN; Bradner JE; Kung AL
    Mol Imaging; 2009; 8(3):140-7. PubMed ID: 19723471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.